Attached files
| file | filename |
|---|---|
| EX-10.28 - EX-10.28 - Dare Bioscience, Inc. | ceru-ex1028_20141231821.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Dare Bioscience, Inc. | Financial_Report.xls |
| EX-32.2 - EX-32.2 - Dare Bioscience, Inc. | ceru-ex322_20141231827.htm |
| EX-32.1 - EX-32.1 - Dare Bioscience, Inc. | ceru-ex321_20141231826.htm |
| EX-31.2 - EX-31.2 - Dare Bioscience, Inc. | ceru-ex312_20141231825.htm |
| EX-31.1 - EX-31.1 - Dare Bioscience, Inc. | ceru-ex311_20141231824.htm |
| 10-K - 10-K - Dare Bioscience, Inc. | ceru-10k_20141231.htm |
| EX-21.1 - EX-21.1 - Dare Bioscience, Inc. | ceru-ex211_20141231823.htm |
| EX-10.31 - EX-10.31 - Dare Bioscience, Inc. | ceru-ex1031_201412311454.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-198126 on Form S-8 of our report dated March 19, 2015, relating to the consolidated financial statements of Cerulean Pharma Inc. appearing in this Annual Report on Form 10-K of Cerulean Pharma Inc. for the year ended December 31, 2014.
/s/ DELOITTE & TOUCHE LLP
Boston, Massachusetts
March 19, 2015